Patient Information

Can patients opt to turn off implantable cardioverter-defibrillators near the end of life?


 

References

Yes, it is reasonable to consider implantable cardioverter-defibrillator (ICD) deactivation if the patient or family wishes. Although ICDs prevent sudden cardiac death in patients with advanced heart failure, their benefit in terminally ill patients is small. More on this difficult decision, and a related commentary, can be found at the Cleveland Clinic Journal of Medicine: http://www.ccjm.org/current-issue/issue-single-view/can-patients-opt-to-turn-off-implantable-cardioverter-defibrillators-near-the-end-of-life/09d58fc5bb0433f014c2406ad4b5f9f5.html.

Recommended Reading

Pediatric BMI increases linked to rises in blood pressure, hypertension risk
MDedge Family Medicine
VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events
MDedge Family Medicine
VIDEO: Octogenarians benefit from ischemic stroke thrombectomy
MDedge Family Medicine
ISC: Carotid surgery, stenting offer patients balanced alternatives
MDedge Family Medicine
Cardiovascular abnormalities persist after preeclamptic pregnancy
MDedge Family Medicine
Hypertension metrics controversial in Core Quality Measures Collaborative
MDedge Family Medicine
Loss of pulmonary vascular distensibility precedes PH
MDedge Family Medicine
Could PCSK9 inhibitors be cost effective for all comers?
MDedge Family Medicine
ACA accelerated hospital readmission reduction efforts
MDedge Family Medicine
Troponin reaffirmed as valuable prognostic marker after PCI
MDedge Family Medicine